+1 650 843 5469 pmerksamer@cooley.com
Philip Merksamer focuses on the representation of life sciences companies in a variety of intellectual property and commercial transactions.
Download full bio
Genesis MedTech Acquires Drug Device Asset From TriReme Medical
Cooley advises Evolutionary Genomics in its partnership with Dole Food Company
Portola Agrees to Sell to Alexion for $1.41 Billion
Vir Biotechnology - $143 Million IPO
Life Sciences Corporate Partnering & Licensing
Life Sciences
Agricultural Sciences & Technology
University of California, Berkeley School of Law (Boalt Hall)JD, 2017
University of California, San FranciscoPhD, Cell Biology2010
Stanford UniversityBS, Biological SciencesWith distinction and honors, 2004
California
United States Patent & Trademark Office
Portola Agrees to Sell to Alexion for $1.41 Billion May 5, 2020
SoftBank Vision Fund Leads $400 Million Series C for Relay Therapeutics December 27, 2018
American Bar Association
+1 650 843 5469 office pmerksamer@cooley.com
3175 Hanover StreetPalo Alto, CA 94304-1130